Month: April 2022

Anoto publishes its annual report 2021 and corrects for a minor change in results 2021

Anoto publishes its annual report 2021 and corrects for a minor change in results 2021

Anoto Group AB (“Anoto” or the “Company”) today publishes its annual report 2021. The report is available on the Company’s website, www.anoto.com. Compared to previously communicated results in the year-end report, Anoto reports two minor changes in the results in the annual report. The first correction is on the consolidated results related to the valuation of goodwill, which was not revalued using exchange rates at 31 December 2021 in the year-end report. By correctly revaluing goodwill based on spot rates at year end 2021, the Group reports a translation gain of MSEK 7.9, which was subsequently included in other comprehensive in the annual report. The corresponding increase in the valuation of goodwill was also reflected in the Group’s consolidated balance sheet, increasing total assets by MSEK 7.9 in the annual report. A further correction...

Continue reading

Thunderbird Resorts 2021 Annual Report Filed

Thunderbird Resorts 2021 Annual Report Filed

ZURICH, April 30, 2022 (GLOBE NEWSWIRE) — Thunderbird Resorts Inc. (“Thunderbird”) (FSE: 4TR; and Euronext: TBIRD) is pleased to announce that its 2021 Annual Report and Audited Consolidated Financial Statements have been filed with the Euronext (“Euronext Amsterdam”) and the Netherlands Authority for Financial Markets (“AFM”). As a Designated Foreign Issuer with respect to Canadian securities regulations, the Annual Report is intended to comply with the rules and regulations set forth by the AFM and the Euronext Amsterdam.  Copies of the Annual Report in the English language will be available at no cost at the Group’s website at www.thunderbirdresorts.com. Copies in the English language are available at no cost at the Group’s operational office in Panama and at the offices of our...

Continue reading

KANZHUN LIMITED Announces Changes to Board Compositions

KANZHUN LIMITED Announces Changes to Board Compositions

BEIJING, April 30, 2022 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ), a leading online recruitment platform in China, today announced that the Company has appointed Ms. Xiehua Wang to the Company’s board of directors (the “Board”) and Ms. Xin Xu has resigned from its Board, effective on April 30, 2022. Ms. Xu’s resignation did not result from any disagreement with the Company. Ms. Xiehua Wang is currently the Vice President of Product of the Company. Ms. Wang joined the Company in October 2016 and has over 10 years of experience in product management in internet companies. Prior to joining the Company, Ms. Wang was a senior product manager of Lianjia (currently known as KE Holdings Inc.), a leading housing transactions and services platform in China. From 2013 to 2016, she served as a senior...

Continue reading

BlueCity Enters into Definitive Agreement for Going-Private Transaction

BlueCity Enters into Definitive Agreement for Going-Private Transaction

BEIJING, April 30, 2022 (GLOBE NEWSWIRE) — BlueCity Holdings Limited (“BlueCity” or the “Company”) (NASDAQ: BLCT), a leading online LGBTQ platform, today announced that it has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Multelements Limited (“Parent”), Diversefuture Limited, a wholly-owned Subsidiary of Parent (the “Merger Sub”), pursuant to which the Company will be acquired by a buyer group in an all-cash transaction (the “Merger”) implying an equity value of the Company of approximately US$60 million for all of the Company’s outstanding ordinary shares (each, a “Share”). Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each Share issued and outstanding immediately prior to the Effective Time will be cancelled and cease to exist in exchange for the right...

Continue reading

<div>Ex-day of dividends allocated by the shareholders' meeting of Invalda INVL held on 30/04/2022</div>

Ex-day of dividends allocated by the shareholders’ meeting of Invalda INVL held on 30/04/2022

The Ordinary General Meeting of Shareholders of Invalda INVL AB (hereinafter – the Company) held on 30 April 2022 passed a resolution to approve the allocation of EUR 0.65 dividends per share for the year 2021, when the total number of shares entitling to dividends is 11,749,032. The total amount allocated for dividends would then be EUR 7,637 thousand. If the increase of the share capital is registered before the shareholders’ rights accounting day, EUR 0.65 per share would also be paid for the newly issued shares. In this case, the amount allocated for dividends would increase to EUR 7,682 thousand. The Company notes that dividends will be paid and the procedure for payment of dividends for the year 2021 will be announced within one month of the General Meeting of Shareholders approving the decision to pay dividends. Dividends...

Continue reading

Audited annual information of Invalda INVL for 2021

Audited annual information of Invalda INVL for 2021

We hereby announce the annual information in the European Single Electronic Format (ESEF) in compliance with the requirements of Commission Delegated Regulation (EU) 2019/815 of 17 December 2018 (zip file attached). This is the official format for the annual information that was approved by the Ordinary General Shareholders‘ Meeting held on 30 April 2022. The annual information is additionally provided in pdf format as a copy of the published ESEF information. The signed independent auditor’s report on the annual information in ESEF format is provided at the end of the pdf file. The person authorized to provide additional information is:Darius Sulnis, President of Invalda INVLE-mail Darius.Sulnis@invl.com   Attachments invaldainvl-2021-12-31-en Invalda INVL financial statement annual report management...

Continue reading

Saniona publishes its Annual Report for 2021

Saniona publishes its Annual Report for 2021

PRESS RELEASE April 30, 2022 Saniona (OMX: SANION), a clinical–stage biopharmaceutical company focused on rare diseases, today announced that the English version of the Annual Report for 2021 is now available on the company’s website, www.saniona.com. For more information, please contact Thomas Feldthus, incoming CEO, +45 22109957; thomas.feldthus@saniona.com This information was submitted for publication, through the agency of the contact person set out above, at 8.00 CEST on 30 April 2022. About Saniona Saniona is a clinical-stage biopharmaceutical company with a mission to leverage its ion channel targeting expertise to discover, develop and deliver innovative rare disease treatments. The company’s most advanced product candidate, Tesomet™, has been progressed into mid-stage clinical trials for hypothalamic obesity and Prader-Willi...

Continue reading

<div>Victory Square Technologies Announces Late Filing of Annual Financial Statements and MD&A</div>

Victory Square Technologies Announces Late Filing of Annual Financial Statements and MD&A

VANCOUVER, British Columbia, April 29, 2022 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or “VST”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) announces that as a result of delays to its audit, the Company’s annual financial statements and accompanying management’s discussion and analysis for the fiscal year ended December 31, 2021 (the “Annual Filings”) are not expected to be finalized by May 2, 2022, being the date that such filings are due under applicable Canadian securities law requirements. The Company has applied for a management cease trade order (the “MCTO“) by the British Columbia Securities Commission. The reason for the anticipated delay is due to the complexity of the valuation process and accounting of one of the acquisitions completed by the Company in the fiscal year and enhanced quality...

Continue reading

Vitru Limited Received Antitrust Clearance for its Business Combination with Unicesumar

Vitru Limited Received Antitrust Clearance for its Business Combination with Unicesumar

FLORIANÓPOLIS, Brazil, April 29, 2022 (GLOBE NEWSWIRE) — Vitru Limited, or Vitru (Nasdaq: VTRU), announced that the General Superintendence of CADE (Administrative Council for Economic Defense – Brazilian antitrust authority) approved today the definitive agreement for a business combination under which Vitru, through its wholly-owned subsidiary Vitru Brasil Empreendimentos, Participações e Comércio S.A., will own 100% of the total share capital of CESUMAR – Centro de Ensino Superior de Maringá Ltda, or “Unicesumar”. The decision is expected to be published in the Official Gazette on May 2, 2022. According to Law No. 12,529/2011, there is an additional 15-day waiting period for CADE’s decision to become final. During this period, commissioners may request to further review the case. Once the waiting period expires and to...

Continue reading

Tarsus to Host Webcast to Review Topline Results from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis

Tarsus to Host Webcast to Review Topline Results from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis

IRVINE, Calif., April 29, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, will hold a webcast on Monday, May 2, 2022 at 5:00am PT/8:00am ET to review the topline results from the Saturn-2 Phase 3 trial for TP-03 (lotilaner ophthalmic solution, 0.25%) for the treatment of Demodex blepharitis and provide a brief corporate update. Webcast Information The webcast can be accessed at the events section of the Tarsus website. After the live webcast, the event will remain archived on the Tarsus website at https://ir.tarsusrx.com/ for 90 days. About Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.